<DOC>
	<DOCNO>NCT01174771</DOCNO>
	<brief_summary>Drug therapy atypical parkinsonism generally consider either ineffective minimal 1 . Therefore , urgent need find alternative therapy treat atypical parkinsonian disorder . Repetitive transcranial magnetic stimulation ( rTMS ) noninvasive tool modulates cortical excitability minimal discomfort hold therapeutic promise treat neurological psychiatric disorder . The basal ganglia-thalamocortical circuit affect Progressive Supranuclear Palsy ( PSP ) Corticocbasal Ganglionic Degeneration ( CBGD ) likely structurally functionally segregate . The 'motor ' circuit implicate parkinsonian akinesia hypokinesia ; 'prefrontal ' circuit implicate work memory mood regulation , link non-motor symptom depression apathy . In proposal , characterize motor prefrontal network dysfunction PSP CBGD patient , propose high-frequency low-frequency rTMS direct separate motor prefrontal cortical target network may show specific selective beneficial effect motor vs. cognitive function PSP CBGD patient , respectively . Quantitative motor outcome measure include time finger tap task . Quantitative cognitive outcome measure comprise visual analogue scale ( VAS ) . If successful , pilot study provide proof principle data suggest potential benefit rTMS PSP/CBGD patient , provide sufficient data experience support future PSP/CBGD study include use rTMS investigate pathophysiology motor non-motor feature PSP CBGD patient .</brief_summary>
	<brief_title>Repetitive Transcranial Magnetic Stimulation ( TMS ) Progressive Supranuclear Palsy Corticobasal Degeneration</brief_title>
	<detailed_description>Background : Drug therapy atypical parkinsonism generally ineffective minimal , novel therapy approach atypical parkinsonian disorder need . Repetitive transcranial magnetic stimulation ( rTMS ) noninvasive tool modulates cortical excitability hold promise treat neurological/psychiatric disorder . The 'motor ' basal ganglia-cortical circuit implicate parkinsonian akinesia hypokinesia ; 'prefrontal ' circuit implicate work memory ( WM ) mood regulation , possibly link depression apathy . Hypothesis : Motor deficit Progressive Supranuclear Palsy ( PSP ) Corticobasal Ganglionic Degeneration ( CBGD ) associate dysfunctional motor network ; emotional deficit PSP/CBGD associate dysfunctional prefrontal network . We hypothesize high-frequency low-frequency rTMS cortical target selectively specifically improve task symptom relevant target PSP CBGD patient , respectively . Aims : To contrast cortical excitability characteristic motor emotional function PSP CBGD patient . To determine selective specific beneficial rTMS effect primary motor ( M1 ) dorsolateral prefrontal ( DLPFC ) cortex cortical excitability characteristic motor emotional function PSP CBGD patient . Design : Ten individual PSP ten CBGD participate within-subject cross-sectional design . Motor outcome measure include time finger tap task comfortable maximal speed . Quantitative cognitive outcome measure comprise visual analogue scale mood state ( VAS ) . After first baseline visit , PSP patient receive high-frequency 5 Hz rTMS two separate visit two site condition ( leave DLPFC vs. affect side M1 ) across subject two within-session task condition ( motor vs. cognitive ) . They also receive sham stimulation separate visit . These three stimulation visit randomize . CBGD patient receive treatment difference receive low-frequency 1 Hz rTMS instead . Relevance : If successful , demonstrate double-dissociation causal functional significance rTMS modulation M1 motor task DLPFC emotional function PSP Vs. CBGD . Exploratory aim conduct . Sufficient data experience future PSP/CBGD intervention study help identify candidate TMS parameter optimal give symptom .</detailed_description>
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Parkinsonian Disorders</mesh_term>
	<mesh_term>Supranuclear Palsy , Progressive</mesh_term>
	<criteria>If adult PSP CBGD : 1 . Must good physical health . If neurologically healthy volunteer : 1 . Must old 35 year 1 . Must implant metal . Dental filling acceptable . 2 . Must personal seizure 1st degree relative history seizures 3 . Must take medication lower seizure threshold .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Transcranial magnetic stimulation</keyword>
	<keyword>Cortical excitability</keyword>
	<keyword>parkinsonism</keyword>
	<keyword>Progressive Supranuclear Palsy</keyword>
	<keyword>Corticobasal Degeneration</keyword>
	<keyword>PSP</keyword>
	<keyword>CBD</keyword>
	<keyword>CBGD</keyword>
</DOC>